Amlodipine/Valsartan [Design Issues]

posted by Bebac user – Egypt, 2023-09-09 08:34 (572 d 13:46 ago) – Posting: # 23713
Views: 4,073

The combination of Amlodipine and valsartan was published as two periods crossover but after checking the variability of Valsartan, it had more than 30%. Therefore, should I in those cases design this study as replicated or un-replicated ?

Complete thread:

UA Flag
Activity
 Admin contact
23,413 posts in 4,924 threads, 1,668 registered users;
134 visitors (1 registered, 133 guests [including 13 identified bots]).
Forum time: 22:20 CEST (Europe/Vienna)

Genius is that which forces
the inertia of humanity to learn.    Henri Bergson

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5